Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Stein A, Evensen"'
Publikováno v:
Tidsskrift for Den norske legeforening.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6904222b043b923063745cea9d12b12
https://doi.org/10.4045/tidsskr.22.0446
https://doi.org/10.4045/tidsskr.22.0446
Publikováno v:
Tidsskrift for Den norske legeforening.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7953e4f0a0ab745f9ae92e757f55eb3a
https://doi.org/10.4045/tidsskr.21.0328
https://doi.org/10.4045/tidsskr.21.0328
Autor:
Stein A. Evensen
Publikováno v:
Tidsskrift for Den norske legeforening.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7b850709b0ae65bcc37dbfadb49c2ca
https://doi.org/10.4045/tidsskr.17.0568
https://doi.org/10.4045/tidsskr.17.0568
Autor:
Stein A. Evensen
Publikováno v:
Tidsskrift for Den norske legeforening.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79e3b1d641f222e57b6323aa4022027f
https://doi.org/10.4045/tidsskr.17.0567
https://doi.org/10.4045/tidsskr.17.0567
Autor:
Stein Arne Evensen, Arvid Heiberg
Publikováno v:
Tidsskrift for Den norske legeforening. 136
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dabc6846c95f63f081f921e09ee96a64
https://doi.org/10.4045/tidsskr.15.1345
https://doi.org/10.4045/tidsskr.15.1345
Publikováno v:
European Journal of Haematology. 38:43-47
SUMMARY Nineteen patients with acute myelogenous leukaemia refractory to regimens including daunorubicin (relapsed or resistant to the induction treatment) received aclarubicin as single-agent chemotherapy in a dose of 40 mg/m2 daily for 5–7 days.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0732d9fc844526e503ccd19817c7c0fa
https://doi.org/10.1111/j.1600-0609.1987.tb00021.x
https://doi.org/10.1111/j.1600-0609.1987.tb00021.x
Autor:
Per Stavem, Stein A. Evensen
Publikováno v:
Acta Medica Scandinavica. 219:79-83
An intermittent combination chemotherapy program was initiated in 1971–79 in 172 patients, aged 15–59 years, with acute leukemia (131 myelogenous (AML) and 41 lymphoblastic (ALL)). Sixteen patients with AML and 6 with ALL have survived for more t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f422d740717bbc1d8f9aeb080ccb5c8e
https://doi.org/10.1111/j.0954-6820.1986.tb03279.x
https://doi.org/10.1111/j.0954-6820.1986.tb03279.x
Autor:
Ragna Følling Elgjo, Stein A. Evensen
Publikováno v:
Scandinavian Journal of Haematology. 9:61-72
Rabbits were injected with platelet antiserum to investigate whether antibody-induced injury of platelets triggers intravascular clotting. More than 97 % of the circulating platelets were acutely removed, and profound thrombocytopenia persisted durin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::557ce253bc71723666f13c5cf20d5ce0
https://doi.org/10.1111/j.1600-0609.1972.tb00914.x
https://doi.org/10.1111/j.1600-0609.1972.tb00914.x
Publikováno v:
Acta Medica Scandinavica. 186:331-335
Four cases of heterozygous β-thalassemia in three generations of a Norwegian family are reported. Hypochromic microcytic anemia with many target cells and a high serum iron concentration suggested the diagnosis; hemoglobin starch-gel electrophoresis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c122fa7991e14050ed209b136ceb060
https://doi.org/10.1111/j.0954-6820.1969.tb01484.x
https://doi.org/10.1111/j.0954-6820.1969.tb01484.x
Publikováno v:
Tissue Antigens. 4:257-261
Endothelial cells separated from the vein of human umbilical cords were capable of stimulating allogeneic lymphocytes in mixed lymphocyte endothelial cultures. The degree of stimulation observed with endothelial cells was generally less than that for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::176a01eaf3af527c8e534f70c11bdff2
https://doi.org/10.1111/j.1399-0039.1974.tb00249.x
https://doi.org/10.1111/j.1399-0039.1974.tb00249.x